Anavex Life Sciences Corp (AVXL)

[Gator328]

See my post # 176175 on 12/26 in response to Tom asking me the same thing....


"Short term pop followed by a plateau followed up by a slow decline through mid-2019, until the price stabilizes out a bit as everyone waits for signs of life from the company in terms of trial updates/announcements on the Retts front."


Two months later: pop from $1.25 to $2.68, followed by a slow decline into the 2.30s. It should hopefully stabilize around this range, give or take 10/15% either direction.

With each upcoming catalyst I think the moves (good or bad) will become more significant and will set new levels of support and resistance. Question is whether the news we receive will be positive? If we go to AdCom, which I suspect we will, it's a crapshoot. Just look at what happened today for a drug that had very solid data and was vying for accelerated approval...